Researchers in Japan have discovered that people with Parkinson's may have lower levels of caffeine in their blood after drinking tea and coffee.

New research demonstrates how the protein alpha-synuclein could cause the loss of cells in Parkinson’s.

Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.

Parkinson's UK funded researchers at the University of York have observed tremors in fruit flies with a genetic mutation linked to Parkinson's.

New fast-track route could shave years off the time it takes for people with Parkinson's to benefit from new and better treatments.

Researchers at Dundee University have solved the 3D structure of PINK1, a protein that plays a protective role in brain cells.

UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.

New research suggests that a type of asthma drug that activates a protein called beta-adrenoceptors, may decrease risk of Parkinson's. 

Results published today make significant strides into our understanding of cell transplants for Parkinson's.

UK researchers have shared promising results of a phase 2 clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's.